Pfizer Inc. (NYSE:PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform…
Read More

Pfizer Inc. (NYSE:PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform…
Read More
Novo Nordisk (NVO) CagriSema trial showed 23% weight loss versus Eli Lilly’s Zepbound at 25.5%. JPMorgan cut CagriSema forecasts by…
Read More